...
首页> 外文期刊>Analytical chemistry >Modular Microsystem for the Isolation, Enumeration, and Phenotyping of Circulating Tumor Cells in Patients with Pancreatic Cancer
【24h】

Modular Microsystem for the Isolation, Enumeration, and Phenotyping of Circulating Tumor Cells in Patients with Pancreatic Cancer

机译:用于胰腺癌患者循环肿瘤细胞的分离,计数和表型分析的模块化微系统

获取原文
获取原文并翻译 | 示例

摘要

In this manuscript, we discuss the development and clinical use of a thermoplastic modular microsystem for the high-throughput analysis of CTCs directly from whole blood. The modular system offers some innovative features that address challenges currently associated with many CTC platforms; it can exhaustively process 7.5 mL of blood in less than 45 min with recoveries >90%. In addition, the system automates the postselection CTC processing steps and thus, significantly reduces assay turnaround time (from selection to enumeration <1.5 h as compared to >8 h for many reported CTC platforms). The system is composed of 3 functional modules including (i) a thermoplastic CTC selection module composed of high aspect ratio (30 μm × 150 μm) channels containing anti-EpCAM antibodies that is scalable in terms of throughput by employing channel numbers ranging from 50 to 320; the channel number is user selected to accommodate the volume of blood that must be processed; (ii) an impedance sensor module for label-less CTC counting; and (iii) a staining and imaging module for the placement of released cells into a 2D array within a common imaging plane for phenotypic identification. To demonstrate the utility of this system, blood samples from patients with local resectable and metastatic pancreatic ductal adenocarcinoma (PDAC) were analyzed. We demonstrate the ability to select EpCAM positive CTCs from PDAC patients in high purity (>86%) and with excellent yields (mean = 53 CTCs per mL for metastatic PDAC patients) using our modular system. In addition, we demonstrate the ability to detect CTCs in PDAC patients with local resectable disease (mean = 11 CTCs per mL).
机译:在本手稿中,我们讨论了用于直接从全血中进行四氯化碳高通量分析的热塑性模块化微系统的开发和临床应用。模块化系统提供了一些创新功能,以解决当前与许多CTC平台相关的挑战。它可以在不到45分钟的时间内彻底处理7.5 mL血液,回收率> 90%。此外,该系统可自动执行选择后CTC的处理步骤,因此可显着减少化验周转时间(与许多报道的CTC平台的> 8 h相比,从选择到枚举的时间少于1.5 h)。该系统由3个功能模块组成,其中包括(i)由高纵横比(30μm×150μm)通道组成的热塑性CTC选择模块,该通道包含抗EpCAM抗体,通过使用50到50之间的通道数可以在吞吐量方面进行扩展320;用户选择通道号以适应必须处理的血液量; (ii)用于无标签CTC计数的阻抗传感器模块; (iii)染色和成像模块,用于将释放的细胞放置在共同成像平面内的二维阵列中以进行表型鉴定。为了证明该系统的实用性,分析了局部可切除和转移性胰腺导管腺癌(PDAC)患者的血液样本。我们展示了使用我们的模块化系统从高纯度(> 86%)的PDAC患者中选择EpCAM阳性CTC的能力,并具有优异的产率(对于转移的PDAC患者,平均= 53 CTCs / mL)。此外,我们证明了在具有局部可切除疾病的PDAC患者中检测CTC的能力(平均= 11 CTCs / mL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号